Editorial
doi: 10.1111/resp.14293.
Epub 2022 May 13.
Ubi pus, ibi evacua: Optimizing intrapleural fibrinolytic therapy in pleural infections
Affiliations
- PMID: 35560748
- DOI: 10.1111/resp.14293
Item in Clipboard
Editorial
Ubi pus, ibi evacua: Optimizing intrapleural fibrinolytic therapy in pleural infections
Respirology.
2022 Jul.
Free article
No abstract available
Keywords: deoxyribonuclease; empyema; intrapleural fibrinolytic therapy; pleural effusion; pleural infection; tissue plasminogen activator.
Comment on
-
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study-2: Use of 2.5 mg alteplase as a starting intrapleural dose.Respirology. 2022 Jul;27(7):510-516. doi: 10.1111/resp.14261. Epub 2022 Apr 19. Respirology. 2022. PMID: 35441458
Similar articles
-
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4. Cochrane Database Syst Rev. 2019. PMID: 31684683 Free PMC article.
-
Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.Chest. 2018 Sep;154(3):550-556. doi: 10.1016/j.chest.2018.01.037. Epub 2018 Feb 6. Chest. 2018. PMID: 29425674
-
Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.Ann Am Thorac Soc. 2018 May;15(5):515-517. doi: 10.1513/AnnalsATS.201711-848PS. Ann Am Thorac Soc. 2018. PMID: 29361235 Free PMC article. Review. No abstract available.
-
Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.Clin Respir J. 2014 Jul;8(3):281-91. doi: 10.1111/crj.12068. Epub 2014 Jan 16. Clin Respir J. 2014. PMID: 24428897 Review.
-
[Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].Pneumologie. 1999 Aug;53(8):373-84. Pneumologie. 1999. PMID: 10483276 Review. German.
References
REFERENCES
-
- Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest. 1949;28(1):173-90.
-
- Altmann ES, Crossingham I, Wilson S, Davies HR. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2019;(10):CD002312.
-
- Lau EPM, Eshraghi M, Dootson K, Yeoh C, Ywe Phu W, Lee YCG, et al. An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection. ERJ Open Res. 2022;8(1):00590-2021.
-
- Scarci M, Abah U, Solli P, Page A, Waller D, van Schil P, et al. EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardiothorac Surg. 2015;48(5):642-53.
-
- Chaddha U, Agrawal A, Feller-Kopman D, Kaul V, Shojaee S, Maldonado F, et al. Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement. Lancet Respir Med. 2021;9(9):1050-64.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
